🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Canada / NCT04604418
Recruiting Observational

Outcomes and Health Care Resource Utilization in Pediatric Congenital Heart Disease Patients Undergoing Non-Cardiac Procedures

NCT04604418 · tracked via the Priya Life Science Canada tracker
Phase
Observational
Started
2020-10-01
Last updated
2026-04-07

Condition(s) studied

Congenital Heart Disease in Children

Investigational drug(s) / intervention(s)

No intervention. It is observational

No intervention. It is observational: No intervention. It is observational

Study summary

The incidence of moderate to severe congenital heart disease (CHD) in the United States is estimated to be 6 per 1000 live-born full term infants. Recent advances in pediatric cardiology, surgery and critical care have significantly improved the survival rates of patients with CHD leading to an increase in prevalence in both children and adults. Children with CHD significant enough to require cardiac surgery frequently also undergo non-cardiac surgical procedures. Analysis of the Pediatric Health Information System database between 2004 and 2012 demonstrated that 41% of children who had undergone surgery to correct CHD in the first year of life also underwent at least one non-cardiac surgery by age 5. With this increased demand for non-cardiac procedures, anesthesiologists, pediatricians and other healthcare providers will encounter patients with repaired or unrepaired CHD and other cardiac diseases in their practice.

However, the information provided by national databases lack granularity and the information from single institutional data is limited.

This project aims to address this knowledge gap in quantifying the risk for cardiac patients coming for noncardiac procedures and identify the health care resource utilization and system to best care for this patient population. To conduct this study, we will create a multi-institutional collaboration between large and small centers to create a unique dataset spanning all the different variables that need to be considered in risk prediction for these patients including patient variables, hospital setting, and providers. The aggregate multiinstitutional data set may be used for benchmarking for national quality improvement efforts.

Eligibility

Sex
ALL
Min age
—
Max age
21 Years
Healthy volunteers
No
Inclusion Criteria: 1. Males or females ages birth to 21 years. 2. Patients diagnosed with congenital heart disease 3. Patients undergoing a noncardiac procedure (surgical or nonsurgical) Exclusion Criteria: 1. Patients with congenial heart disease undergoing a cardiac surgical procedure including pacemakers. 2. Patients with congenital heart disease undergoing a catheterization(diagnostic or interventional) or an electrophysiology study

Primary outcome measure(s)

Trial sites (10)

FacilityCityRegionStatus
University of California, Los Angeles Los Angeles California Active Not Recruiting
Children's National Medical Center Washington D.C. District of Columbia Recruiting
Children's Healthcare of Atlanta - Egleston Hospita Atlanta Georgia Active Not Recruiting
Boston Children's Hospital Boston Massachusetts Recruiting
University of Minnesota Medical Center Minneapolis Minnesota Active Not Recruiting
Children's Hospital of Philadelphia Philadelphia Pennsylvania Recruiting
Vanderbilt University Medical Center Nashville Tennessee Recruiting
Texas Children's Hospital Houston Texas Recruiting
Children's Hospital of the King's Daughter Norfolk Virginia Terminated
Hospital for Sick Kids Toronto Ontario Recruiting

More Boston Children's Hospital trials in Canada

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04604418 on ClinicalTrials.gov ↗ ← All trials in Canada